Tag: WSC 2024
Further research on balloon guide catheters required following inconclusive PROTECT-MT results
Recently presented results from the PROTECT-MT randomised controlled trial (RCT) have indicated worse functional outcomes following stroke thrombectomy with a balloon guide catheter (BGC)...
Female sex, disease severity and vasospasm among predictors of post-SAH delayed...
A meta-analysis of more than 4,500 patients, presented recently at the 16th World Stroke Congress (WSC; 23–26 October, Abu Dhabi, United Arab Emirates), has revealed...
First prospective Indian thrombectomy registry shows high revascularisation rates and confirms...
Data from a registry claimed to be the first prospective registry on mechanical thrombectomy for stroke in India have revealed a number of key...
“Transformative” new data advocate early blood-thinning therapy in patients with atrial...
People with atrial fibrillation (AF) who have a stroke could benefit from receiving blood-thinning treatments—known as direct oral anticoagulants (DOACs)—at an earlier stage than...
TASTE-2 results suggest ‘significant reduction’ in stroke-related disability with Sanbexin
Simcere Pharmaceutical Group has announced that a new study with major clinical findings regarding Sanbexin—an edaravone-dexborneol concentrated solution for injection—was recently presented at the...
Roughly half of all healthy life lost to stroke is caused...
The latest analysis of the Global Burden of Disease, Injuries and Risk Factors study (GBD), assessing data ranging from 1990–2021, has indicated that roughly...
